This whitepaper discusses GenAI’s synthetic data generation capabilities for privacy protection in clinical trials and patient records. It enhances data protection mechanisms and enables real-time compliance monitoring, reducing the risk of non-compliance penalties. As GenAI technologies advance, they are expected to become more integral to regulatory strategies, aiding in predictive analysis of regulatory trends and optimizing compliance efficiency.